Denosumab in hypercalcemia of malignancy: A case series

Conclusions
Denosumab helped decrease calcium in patients with hypercalcemia of malignancy. However, symptomatic hypocalcemia may result from denosumab in hypercalcemia of malignancy.

Source: Journal of Oncology Pharmacy Practice - February 22, 2015 Category: Cancer & Oncology Authors: Dietzek, A., Connelly, K., Cotugno, M., Bartel, S., McDonnell, A. M. Tags: Case Reports Source Type: research